Addiction Neuromodulation System

In the prior Mitacs funding cluster, a clinical trial of opioid addiction was initiated and approved by both Health Canada and the ethics board of the Saint Joseph General Hospital.
This research project expands upon that work. A smoking cravings reduction program using SmartStim transcranial direct current stimulation (tDCS) has been initiated by NorDocs, and Quit4 (an established smoking cessation program) is an early adopter. The projects in this cluster all focus upon optimizing and studying this new business. Each intern’s project is related to investigating this novel paradigm for reducing cravings with tDCS, and investigating the details of the efficacy of this program. The benefits of this project to NorDocs include 1) the potential for improved adoption of SmartStim technology by customers, 2) a better understanding of how to improve procedures related to SmartStim

Faculty Supervisor:

Miodrag Bolic

Student:

Partner:

Nuraleve Inc;Brian Dressler Medicine Professional Corporation

Discipline:

Engineering

Sector:

Professional, scientific and technical services

University:

University of Ottawa

Program: